A round burgundy crest emblem with simple gold ring detailing, plain and formal in style
A wide horizontal photograph of mountain scenery near Banff with pale turquoise sky, dark evergreen slopes, and a soft muted mood
A round burgundy crest emblem mirroring the first, with plain gold ring detailing and a formal quiet mood

Annual Scientific Meeting of the Canadian Organization of Medical Physicists — July 9–12, 2014, The Banff Centre, Banff, Alberta, Canada

The medical physicist's role in modern SBRT practice

Stereotactic body radiation therapy has transformed modern radiation oncology over the past two decades, evolving from a niche technique into a mainstream option for early-stage lung tumours, oligometastatic disease, and selected liver and prostate lesions. As hypofractionated regimens delivering ablative doses in just a handful of fractions become routine, the medical physicist stands at the centre of every safe and accurate treatment.

Across Australian cancer centres in Sydney, Melbourne, Brisbane and Perth, the discipline now sits within a tightly regulated framework. The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) sets the national safety standards, while the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) governs training and professional certification. This regulatory scaffolding gives physicists clear accountability for the technical integrity of every course of stereotactic radiotherapy.

The 2014 Annual Scientific Meeting of the Canadian Organization of Medical Physicists, hosted in Banff, addressed many of the dosimetric, geometric and workflow challenges that resonate in Australian clinics as well. Practitioners keen to revisit those discussions can browse the archived scientific programme for the meeting, which captured several sessions directly relevant to small-field dosimetry and clinical audits.

The role itself has broadened well beyond traditional chart-checking and machine calibration. Today's physicist in an SBRT programme contributes to commissioning, peer review, multidisciplinary team discussions, vendor evaluation and ongoing service improvement, often shaping how a centre invests in new technology.

Stereotactic body radiation therapy and the Australian clinical landscape

In Australian radiation oncology departments the technique is widely referred to as SABR — stereotactic ablative radiotherapy — although the international literature still favours the acronym SBRT. Whichever term a department prefers, the underlying physics is identical: high dose per fraction, steep dose gradients, and tight margins that demand exceptional geometric precision.

Public and private providers alike have adopted the modality, with Medicare Benefits Schedule rebates available for several lung and bone indications. Centres in Adelaide, Canberra and the Gold Coast have introduced lung SABR programmes over the past decade, and prostate SBRT in five fractions has become a notable growth area, particularly in private metropolitan clinics.

The clinical enthusiasm brings physics challenges that simply do not exist in conventional radiotherapy. Small field sizes challenge most commercial dose calculation algorithms, motion interplay effects can perturb dose distributions, and the margin for error shrinks dramatically when a single fraction delivers more than ten gray.

Commissioning, dosimetry and quality assurance challenges

Commissioning an SBRT programme begins long before the first patient is treated. Medical physicists must characterise the linear accelerator's small-field output factors, validate dose calculation algorithms against measured data, and design a comprehensive quality assurance programme covering both the treatment unit and ancillary equipment.

International guidance, particularly the IAEA-AAPM TRS-483 code of practice, has reshaped how Australian physicists approach this work. Detectors such as microDiamond, plastic scintillators and unshielded diodes have largely replaced traditional ion chambers for field sizes below three centimetres. Many centres also rely on independent audit services run through the ACPSEM to verify baseline output.

The work does not end at commissioning. Daily, weekly and monthly QA protocols must detect drift in multileaf collimator positioning, image guidance alignment and couch accuracy. End-to-end testing using anthropomorphic phantoms has become a regulatory expectation in most Australian jurisdictions, and physicists typically coordinate these tests alongside radiation therapists.

Treatment planning, motion management and dose calculation

Treatment planning for stereotactic body radiation therapy requires a different mindset to conventional planning. Dose constraints are pushed harder, normal tissue tolerances are stretched, and planners must balance target coverage against the risk of severe toxicity in adjacent organs such as the spinal cord, duodenum or central airways.

Motion management has become a defining feature of modern SBRT. Four-dimensional CT captures tumour trajectory across the breathing cycle, while abdominal compression, deep inspiration breath-hold and real-time tracking systems help mitigate motion. In Australian centres, breath-hold techniques are particularly popular for left-sided breast and lung treatments, where cardiac and pulmonary sparing can be substantially improved.

Dose calculation algorithms have evolved in parallel. Modern linear accelerator platforms now ship with collapsed-cone or Monte Carlo engines capable of resolving dose in heterogeneous media, including lung and bone interfaces. Physicists work closely with planners to ensure these algorithms are commissioned appropriately and that delivery techniques such as volumetric modulated arc therapy are tailored to the steep gradients that define a good stereotactic plan.

Image guidance and adaptive strategies in modern practice

Image guidance underpins every fraction of SBRT. Cone-beam CT, stereoscopic kilovoltage imaging and surface-guided systems each play a role in aligning the patient to the planning target, often with sub-millimetre tolerances. ExacTrac systems are popular in cranial and spine work, while abdominal SBRT increasingly relies on fiducial markers or electromagnetic transponders for soft-tissue alignment.

Adaptive strategies are gaining traction as well. Daily CBCT datasets can be used to monitor anatomical change, replan when targets drift outside tolerance, and trigger replanning reviews. The shift places fresh responsibilities on the physicist, who must oversee image quality, manage deformation algorithms, and decide when replanning is genuinely worthwhile rather than a false economy.

The resource implications matter in Australian practice. Private clinics often run tight staffing ratios, and the time taken to review and replan must be justified against throughput. Public centres face similar pressure, although multidisciplinary case reviews help distribute the cognitive load across the team.

Credentialing, audits and continuing professional development

Becoming a certified medical physicist in Australia typically involves completion of the ACPSEM Training, Education and Assessment Programme (TEAP), followed by certification through the ACPSEM Board of Examiners. Colleagues considering an international credential can review the structure of comparable certification pathways through resources such as the CCPM certification examinations portal hosted on the conference platform.

Continuing professional development is no longer optional. Registration with the Australian Health Practitioner Regulation Agency requires evidence of ongoing learning, and most employers expect physicists to maintain active memberships of both the ACPSEM and the international equivalent bodies.

Clinical audits remain a cornerstone of safety. Multidisciplinary chart reviews, independent dose check audits and machine performance trend analysis all sit within the physicist's portfolio. These activities dovetail with the broader audit culture encouraged by ARPANSA and the relevant state regulators.

Practical steps for clinicians building an SBRT service

  • Map every clinical indication against available evidence, reimbursement arrangements and existing equipment before committing to a programme.
  • Commission each treatment technique end-to-end with multiple detectors and at least one independent audit.
  • Develop written motion management protocols that cover simulation, planning and delivery, and rehearse them with the wider team.
  • Establish a peer-review workflow that includes a physicist at every major decision point, from target definition to plan approval.
  • Invest in long-term QA records that allow trend analysis, not just pass-fail reporting.
  • Plan staffing realistically, recognising that SBRT demands more physicist time per patient than conventional courses.
  • Schedule annual protocol reviews to incorporate new evidence, audit findings and software updates.

The 2014 COMP Annual Scientific Meeting remains a valuable reference point for physicists working in stereotactic body radiation therapy. Practitioners planning to revisit the scientific programme, abstracts and educational sessions are encouraged to explore the archived material through the conference website and integrate the lessons into their own departmental protocols. The technical foundations discussed in Banff continue to influence clinical practice in Australian centres today, and the conversations begun there still shape how departments refine their SBRT programmes for safer, more accurate patient care.